Complete inhibition of liver acetyl-CoA carboxylase activity is required to exacerbate liver tumorigenesis in mice treated with diethylnitrosamine

Abstract Background The metabolic pathway of de novo lipogenesis (DNL) is upregulated in fatty liver disease and liver cancer. Inhibitors of DNL are in development for the treatment of these disorders; however, our previous study showed that blocking DNL unexpectedly exacerbated liver tumorigenesis...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Riya Shrestha, Calum S. Vancuylenburg, Martina Beretta, Mingyan Zhou, Divya P. Shah, Ellen M. Olzomer, Sian L. Richards, Kyle L. Hoehn, Frances L. Byrne
Formáid: Alt
Teanga:English
Foilsithe / Cruthaithe: BMC 2024-11-01
Sraith:Cancer & Metabolism
Ábhair:
Rochtain ar líne:https://doi.org/10.1186/s40170-024-00363-1